Jim Wassil, CHIEF OPERATING OFFICER at Vaxcyte, Inc. (PCVX), sold 16,000 shares at $83.69 ($1.3M) on 2025-01-02, disclosed to the SEC on 2025-01-03.
Scheduled sale ($1.3M) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.88 | 1,356 | $112K | 8.4% |
| 2 | $82.88 | 1,356 | $112K | 8.4% |
| 3 | $83.69 | 5,483 | $459K | 34.3% |
| 4 | $83.69 | 5,483 | $459K | 34.3% |
| 5 | $84.43 | 1,161 | $98K | 7.3% |
| 6 | $84.43 | 1,161 |
| $98K |
| 7.3% |
| Total | $83.66 avg | 16,000 | $1.3M | 100% |
| Filing → |
| PCVX | SELL | 2026-09-02 | $212K | — | Filing → |
| PCVX | SELL | 2026-08-05 | $121K | — | Filing → |
| PCVX | SELL | 2026-07-06 | $127K | — | Filing → |